Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity.
CRISPR/Cas
DMR
FR900359
G protein
G protein-coupled receptor (GPCR)
YM-254890
label-free
pharmacology
signal transduction
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
12 04 2019
12 04 2019
Historique:
received:
20
12
2018
revised:
28
01
2019
pubmed:
13
2
2019
medline:
15
10
2019
entrez:
13
2
2019
Statut:
ppublish
Résumé
Transmembrane signals initiated by a range of extracellular stimuli converge on members of the Gq family of heterotrimeric G proteins, which relay these signals in target cells. Gq family G proteins comprise Gq, G11, G14, and G16, which upon activation mediate their cellular effects via inositol lipid-dependent and -independent signaling to control fundamental processes in mammalian physiology. To date, highly specific inhibition of Gq/11/14 signaling can be achieved only with FR900359 (FR) and YM-254890 (YM), two naturally occurring cyclic depsipeptides. To further development of FR or YM mimics for other Gα subunits, we here set out to rationally design Gα16 proteins with artificial FR/YM sensitivity by introducing an engineered depsipeptide-binding site. Thereby we permit control of G16 function through ligands that are inactive on the WT protein. Using CRISPR/Cas9-generated Gαq/Gα11-null cells and loss- and gain-of-function mutagenesis along with label-free whole-cell biosensing, we determined the molecular coordinates for FR/YM inhibition of Gq and transplanted these to FR/YM-insensitive G16. Intriguingly, despite having close structural similarity, FR and YM yielded biologically distinct activities: it was more difficult to perturb Gq inhibition by FR and easier to install FR inhibition onto G16 than perturb or install inhibition with YM. A unique hydrophobic network utilized by FR accounted for these unexpected discrepancies. Our results suggest that non-Gq/11/14 proteins should be amenable to inhibition by FR scaffold-based inhibitors, provided that these inhibitors mimic the interaction of FR with Gα proteins harboring engineered FR-binding sites.
Identifiants
pubmed: 30745359
pii: S0021-9258(20)36643-6
doi: 10.1074/jbc.RA118.007250
pmc: PMC6463727
pii:
doi:
Substances chimiques
Depsipeptides
0
Enzyme Inhibitors
0
FR900359
0
GTP-Binding Protein alpha Subunits
0
Peptides, Cyclic
0
YM-254890
0
Banques de données
PDB
['3AH8']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5747-5758Informations de copyright
© 2019 Malfacini et al.
Références
Mol Pharmacol. 2007 Aug;72(2):219-30
pubmed: 17430994
Cell. 1995 Dec 15;83(6):1047-58
pubmed: 8521505
Nat Biotechnol. 2010 Sep;28(9):943-9
pubmed: 20711173
J Biol Chem. 2018 Mar 30;293(13):4752-4766
pubmed: 29382719
Annu Rev Biochem. 1987;56:615-49
pubmed: 3113327
Nat Commun. 2016 Mar 09;7:10895
pubmed: 26955961
Curr Opin Cell Biol. 1996 Apr;8(2):189-96
pubmed: 8791425
J Biol Chem. 2018 Dec 21;293(51):19586-19599
pubmed: 30352874
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Nat Med. 2013 Jan;67(1):196-201
pubmed: 22388972
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13666-71
pubmed: 20639466
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3629-38
pubmed: 27298341
Nat Chem. 2016 Nov;8(11):1035-1041
pubmed: 27768111
Pharmacol Rev. 2002 Sep;54(3):527-59
pubmed: 12223533
Science. 2006 Apr 21;312(5772):443-6
pubmed: 16627746
Br J Pharmacol. 2008 Jun;154(4):890-900
pubmed: 18536740
J Biol Chem. 2015 Oct 23;290(43):25974-85
pubmed: 26338704
J Nat Prod. 2018 Jul 27;81(7):1628-1635
pubmed: 29943987
Trends Biochem Sci. 1992 Oct;17(10):383-7
pubmed: 1455506
Nature. 2002 Apr 25;416(6883):878-81
pubmed: 11976690
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13453-13458
pubmed: 29208709
Org Lett. 2015 May 1;17(9):2270-3
pubmed: 25875152
Curr Opin Struct Biol. 2016 Dec;41:247-254
pubmed: 27871057
J Biol Chem. 2016 Apr 1;291(14):7505-16
pubmed: 26865629
Nature. 1993 Dec 16;366(6456):654-63
pubmed: 8259210
Nat Commun. 2015 Dec 14;6:10156
pubmed: 26658454
Nature. 2011 Sep 28;477(7366):611-5
pubmed: 21956331
Sci Signal. 2008 Jun 24;1(25):re5
pubmed: 18577758
Bioorg Med Chem. 2004 Jun 15;12(12):3125-33
pubmed: 15158780
J Biol Chem. 2005 Nov 4;280(44):36701-7
pubmed: 16141214
Naunyn Schmiedebergs Arch Pharmacol. 2002 Jan;365(1):50-5
pubmed: 11862333
Sci Transl Med. 2017 Sep 13;9(407):
pubmed: 28904224
Br J Pharmacol. 2009 Dec;158(7):1695-704
pubmed: 19917067
Platelets. 2015;26(8):771-8
pubmed: 25734215
Prog Biophys Mol Biol. 2003 Oct;83(2):101-30
pubmed: 12865075
Nat Rev Mol Cell Biol. 2008 Jan;9(1):60-71
pubmed: 18043707
Angew Chem Int Ed Engl. 2018 Jan 15;57(3):836-840
pubmed: 29194875
Nat Protoc. 2011 Oct 20;6(11):1748-60
pubmed: 22015845
Nature. 1996 Jan 25;379(6563):311-9
pubmed: 8552184
Eur J Med Chem. 2018 Aug 5;156:847-860
pubmed: 30055466
BMC Evol Biol. 2018 Apr 11;18(1):51
pubmed: 29642851
Annu Rev Biochem. 1997;66:639-78
pubmed: 9242920
Curr Opin Struct Biol. 2014 Aug;27:63-8
pubmed: 24907460
Sci Signal. 2011 Feb 08;4(159):ra8
pubmed: 21304159
ChemMedChem. 2017 Jun 7;12(11):830-834
pubmed: 28509439
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2669-73
pubmed: 208069
Sci STKE. 2004 Jan 27;2004(218):re3
pubmed: 14762218
Br J Pharmacol. 2006 Jan;147 Suppl 1:S46-55
pubmed: 16402120
J Biol Chem. 2004 Nov 12;279(46):47438-45
pubmed: 15339913
J Biol Chem. 2006 Jun 16;281(24):16757-67
pubmed: 16611642
J Biol Chem. 2015 May 29;290(22):13678-91
pubmed: 25869129
J Mol Biol. 2013 Jul 10;425(13):2288-98
pubmed: 23602809
Science. 2015 Jun 19;348(6241):1361-5
pubmed: 26089515
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7275-9
pubmed: 22529365
Org Lett. 2015 Feb 6;17(3):492-5
pubmed: 25590672
Nature. 1988 Jun 23;333(6175):784-6
pubmed: 3386721
Science. 1991 May 10;252(5007):802-8
pubmed: 1902986
Nat Cell Biol. 2003 Mar;5(3):231-5
pubmed: 12598904
J Biol Chem. 2009 May 15;284(20):13413-21
pubmed: 19286657
Proc Natl Acad Sci U S A. 1982 May;79(10):3129-33
pubmed: 6954463
J Biol Chem. 2016 Sep 2;291(36):18915-31
pubmed: 27385588
ChemMedChem. 2018 Aug 20;13(16):1634-1643
pubmed: 29873888
Science. 1995 Jan 20;267(5196):383-6
pubmed: 7529940
Science. 1992 Jan 10;255(5041):178-83
pubmed: 1553543
Nat Commun. 2018 May 18;9(1):1996
pubmed: 29777099
Sci Signal. 2018 Sep 04;11(546):
pubmed: 30181242
Nat Rev Drug Discov. 2018 Nov;17(11):789-803
pubmed: 30262890